Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 81749D107 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Baker Bros. Advisors LP
13D
|
16.1% |
2/14/2025
Event 2/12/2025
|
||
| Baker Bros. Advisors LP | 16.1% | |||
| Baker Bros. Advisors (GP) LLC | 16.1% | |||
| Julian C. Baker | 16.1% | |||
| Felix J. Baker | 16.1% | |||
|
Whetstone Capital Advisors, LLC
13G/A
|
8.6% |
5/1/2026
Event 3/31/2026
|
||
| Whetstone Capital Advisors, LLC | 8.6% | |||
| David Atterbury | 8.6% | |||
|
Chione Ltd
13D/A
|
7.6% |
2/14/2025
Event 2/11/2025
|
||
| Chione Ltd. | 7.6% | |||
| Marcin Czernik | 7.6% | |||
| Andreas Hadjimichael | 7.6% | |||
| Anastasis Nikolaou | 7.6% | |||
| Wiaczeslaw Smolokowski | 7.6% | |||
|
Aberdeen Group plc
13G/A
|
7.2% |
7/15/2026
Event 6/30/2026
|
||
| Aberdeen Group plc | 7.2% | |||
| abrdn Inc. | 7.2% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (2) | ||||
| Vivo Capital IX, LLC 13G/A | 4.5% |
5/15/2025
Event 3/31/2025
|
||
|
RA Capital Management, L.P.
13G/A
|
0% |
8/14/2025
Event 6/30/2025
|
||
| RA Capital Management, L.P. | 0% | |||
| Peter Kolchinsky | 0% | |||
| Rajeev Shah | 0% | |||
| RA Capital Healthcare Fund, L.P. | 0% | |||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 1 | 255 | $533.00 |
| 2026 Q2 | 47 | 17.1 M | $31.0 M |
| 2026 Q1 | 57 | 19.9 M | $40.5 M |
| 2025 Q4 | 58 | 17.7 M | $52.4 M |
| 2025 Q3 | 63 | 18.2 M | $55.6 M |
| 2025 Q2 | 63 | 18.6 M | $51.5 M |
| 2025 Q1 | 74 | 20.2 M | $74.4 M |
| 2024 Q4 | 78 | 18.1 M | $147 M |
| 2024 Q3 | 64 | 18.9 M | $147 M |
| 2024 Q2 | 70 | 16.8 M | $99.7 M |
| 2024 Q1 | 56 | 14.8 M | $134 M |
| 2023 Q4 | 50 | 11.1 M | $67.3 M |
| 2023 Q3 | 29 | 8.86 M | $16.5 M |
| 2023 Q2 | 34 | 9.52 M | $31.4 M |
| 2023 Q1 | 36 | 9.53 M | $36.5 M |
| 2022 Q4 | 30 | 7.04 M | $8.86 M |
| 2022 Q3 | 36 | 8.70 M | $13.9 M |
| 2022 Q2 | 31 | 8.66 M | $14.2 M |
| 2022 Q1 | 46 | 9.66 M | $36.6 M |
| 2021 Q4 | 38 | 9.28 M | $63.8 M |
| 2021 Q3 | 37 | 8.65 M | $96.1 M |